HOT TOPIC: Mitigating Iron Deficiency in Blood Donors/Review of Updated AABB Recommendations in Association Bulletin 17-02

​Please note: AABB reserves the right to make updates to this program.

Live Program Date: Monday, May 8, 2017 - On-Demand Available

Master Program Number: 17EL-199 (see program format numbers below under Registration)

Educational Track: Technical/Clinical
Topic: Transfusion Medicine
Intended Audience: Physicians, Scientists, Technologists, Managers/Supervisors, Laboratory staff, Medical Directors, Students, Fellows, Residents, Hospital Blood Banks
Teaching Level: Intermediate

Director: NuJehan Quraishy, MD, Assistant Medical Director, Transfusion Medicine, Assistant Professor, Lerner College of Medicine, Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio
Moderator: Steven Kleinman, MD, Senior Medical Advisor, AABB, Bethesda, MD
Speakers: Joseph E. Kiss, MD, Medical Director, Hemapheresis and Blood Services, The Institute for Transfusion Medicine, Professor of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA; Ralph Vassallo, MD, Chief Medical & Scientific Officer, Blood Systems, Inc., Scottsdale, AZ

Learning Objectives

After participating in this educational activity, participants should be able to:

  • Describe the major scientific studies that have recently increased knowledge about mitigating iron deficiency in blood donors.
  • Outline clinical consequences that may result from iron deficiency.
  • Discuss the rationale for current AABB recommendations for mitigating iron deficiency in subgroups of blood donors.

Program Description

In March 2017, AABB issued new recommendations to blood collection establishments regarding updated strategies to limit or prevent iron deficiency in blood donors. The recommendations of Association Bulletin #17-02 supersede Association Bulletin #12-03. The recommendations are based on scientific studies that show the frequency and duration of iron deficiency; selected subpopulations at risk; and, effective intervention strategies, all of which will be discussed in this eCast.


   Program #
Single Viewer: On-Demand Register17EL-4035-199
Group Viewing: On-Demand Register17EL-8035-199

Speaker Biographies

Dr. Joseph E. Kiss is the Medical Director of Therapeutic Hemapheresis and Blood Services at The Institute for Transfusion Medicine (ITxM), Pittsburgh, PA. He also holds an appointment as Professor of Medicine in the Division of Hematology-Oncology at the University of Pittsburgh, where he practices and teaches consultative hematology. He is an active member of several NHLBI-funded research initiatives, including the REDS-II and III programs. His research interests center on studies in thrombotic microangiopathies, particularly thrombotic thrombocytopenic purpura (TTP), and iron-deficiency. Dr. Kiss received his BA from Boston University and his MD from Georgetown University. His medical internship, residency, and chief medical residency were conducted at the University of Pittsburgh. Dr. Kiss did a fellowship in Hematology/Oncology at the Hospital of the University of Pennsylvania in Philadelphia, PA, followed by a Blood Banking fellowship with the University of Pittsburgh. He is a member of the AABB, the American Society of Hematology (ASH), and the American Society For Apheresis (ASFA).

Dr. Ralph Vassallo is the Chief Medical & Scientific Officer of Blood Systems, Inc. in Scottsdale, Arizona.  He received his bachelor’s and medical degrees from the University of Pennsylvania, and subsequently completed a residency in Internal Medicine and fellowship in Hematology/Oncology at the Hospital of the University of Pennsylvania.

Prior to joining Blood Systems in 2014, Dr. Vassallo was the Chief Medical Officer of the American Red Cross Blood Services’ East Division, at their Penn-Jersey region in Philadelphia.  From 1992-2002, Dr. Vassallo was the Director of Medical Education and a hospital administrator for the 3-hospital Aria Health System in Philadelphia. 

An AABB member, Dr. Vassallo is immediate past chair of the Circular of Information Task Force and currently chairs the Donor Health & Safety Committee. He serves on the Executive Committee of the international Biomedical Excellence for Safer Transfusion Collaborative and is on the editorial boards of Transfusion and Transfusion and Apheresis Science.